PRESS RELEASE
Aix-en-Provence, 25 July 2023
Half-year liquidity contract statement
Affluent Medical (Euronext Paris: FR0013333077 – AFME)
Public limited company with a capital of € 30 896 652
Registered office: 320, avenue Archimède Les Pléiades III - Bâtiment B 13100 Aix-en-Provence - France
837 722 560 R.C.S. on the Aix-en-Provence Trade and Companies Register
Under the liquidity contract entered into between Affluent Medical and Kepler Cheuvreux, the following resources appeared on the liquidity account on June 30th 2023:
- 124,232 shares
- € 39,485.10
- Number of executions on buy side on semester: 245
- Number of executions on sell side on semester: 129
- Traded volume on buy side on semester: 35,717 shares for € 50,544.84
- Traded volume on sell side on semester: 21,629 shares for € 32,173.80
As a reminder:
• the following resources appeared on the last half year statement on 31 December 2022 on the liquidity account:
- 110,144 shares
- € 22,697.72
- Number of executions on buy side on semester: 333
- Number of executions on sell side on semester: 208
- Traded volume on buy side on semester: 32,258 shares for € 82,181.80
- Traded volume on sell side on semester: 13,900 shares for € 33,571.60
• the following resources appeared on the liquidity account when the activity started:
The implementation of this report is carried out in accordance with AMF Decision N°2021-01 of June 22nd 2021 renewing the implementation of liquidity contracts for shares as an accepted market practice.
|
Aggregate buy/sell transactions for each trading day
Period from 02/01/2023 to 30/06/2023
|
|
DATE
|
BUY SIDE
|
SELL SIDE
|
|
Number of executions
|
Number of shares
|
Traded volume in EUR
|
Number of executions
|
Number of shares
|
Traded volume in EUR
|
|
02/01/2023
|
4
|
400
|
660.00
|
-
|
-
|
-
|
|
04/01/2023
|
-
|
-
|
-
|
1
|
100
|
166.00
|
|
05/01/2023
|
-
|
-
|
-
|
2
|
5
|
8.30
|
|
06/01/2023
|
1
|
1
|
1.66
|
1
|
1
|
1.66
|
|
09/01/2023
|
-
|
-
|
-
|
2
|
158
|
267.02
|
|
10/01/2023
|
3
|
300
|
501.00
|
-
|
-
|
-
|
|
11/01/2023
|
1
|
200
|
334.00
|
1
|
137
|
231.53
|
|
12/01/2023
|
3
|
400
|
664.00
|
-
|
-
|
-
|
|
16/01/2023
|
2
|
200
|
332.00
|
2
|
200
|
340.00
|
|
17/01/2023
|
3
|
600
|
996.00
|
-
|
-
|
-
|
|
18/01/2023
|
1
|
200
|
328.00
|
2
|
200
|
338.00
|
|
19/01/2023
|
3
|
201
|
337.68
|
1
|
1
|
1.70
|
|
20/01/2023
|
1
|
1
|
1.68
|
1
|
1
|
1.68
|
|
24/01/2023
|
4
|
700
|
1 169.00
|
-
|
-
|
-
|
|
25/01/2023
|
4
|
601
|
997.66
|
1
|
1
|
1.70
|
|
30/01/2023
|
1
|
200
|
328.00
|
1
|
1
|
1.67
|
|
31/01/2023
|
1
|
50
|
81.50
|
-
|
-
|
-
|
|
01/02/2023
|
2
|
55
|
89.65
|
-
|
-
|
-
|
|
02/02/2023
|
-
|
-
|
-
|
1
|
68
|
113.56
|
|
03/02/2023
|
-
|
-
|
-
|
2
|
170
|
283.90
|
|
06/02/2023
|
-
|
-
|
-
|
2
|
61
|
101.87
|
|
09/02/2023
|
3
|
296
|
482.48
|
1
|
1
|
1.63
|
|
10/02/2023
|
6
|
1 000
|
1 470.00
|
-
|
-
|
-
|
|
13/02/2023
|
-
|
-
|
-
|
5
|
600
|
918.00
|
|
14/02/2023
|
4
|
770
|
1 185.80
|
1
|
200
|
320.00
|
|
15/02/2023
|
3
|
400
|
592.00
|
-
|
-
|
-
|
|
16/02/2023
|
5
|
524
|
765.04
|
-
|
-
|
-
|
|
17/02/2023
|
6
|
876
|
1 261.44
|
-
|
-
|
-
|
|
DATE
|
BUY SIDE
|
SELL SIDE
|
|
Number of executions
|
Number of shares
|
Traded volume in EUR
|
Number of executions
|
Number of shares
|
Traded volume in EUR
|
|
20/02/2023
|
1
|
200
|
284.00
|
-
|
-
|
-
|
|
21/02/2023
|
1
|
1
|
1.40
|
5
|
501
|
726.45
|
|
22/02/2023
|
3
|
400
|
572.00
|
2
|
400
|
592.00
|
|
23/02/2023
|
7
|
1 200
|
1 848.00
|
15
|
3 006
|
4 779.54
|
|
24/02/2023
|
12
|
1 802
|
2 703.00
|
1
|
194
|
310.40
|
|
27/02/2023
|
3
|
1 300
|
1 950.00
|
2
|
71
|
113.60
|
|
28/02/2023
|
2
|
200
|
296.00
|
-
|
-
|
-
|
|
01/03/2023
|
4
|
600
|
870.00
|
-
|
-
|
-
|
|
02/03/2023
|
6
|
900
|
1 260.00
|
6
|
1 792
|
2 795.52
|
|
03/03/2023
|
4
|
873
|
1 292.04
|
-
|
-
|
-
|
|
06/03/2023
|
8
|
1 427
|
1 997.80
|
-
|
-
|
-
|
|
07/03/2023
|
4
|
901
|
1 234.37
|
2
|
501
|
711.42
|
|
08/03/2023
|
4
|
900
|
1 215.00
|
-
|
-
|
-
|
|
09/03/2023
|
2
|
1 000
|
1 400.00
|
12
|
5 508
|
8 262.00
|
|
10/03/2023
|
1
|
500
|
705.00
|
2
|
2 000
|
2 900.00
|
|
13/03/2023
|
1
|
500
|
720.00
|
1
|
1 000
|
1 480.00
|
|
14/03/2023
|
3
|
501
|
721.44
|
1
|
1
|
1.45
|
|
15/03/2023
|
2
|
1 001
|
1 401.40
|
1
|
1
|
1.45
|
|
16/03/2023
|
10
|
2 775
|
3 718.50
|
-
|
-
|
-
|
|
17/03/2023
|
1
|
225
|
292.50
|
3
|
1 001
|
1 361.36
|
|
20/03/2023
|
1
|
200
|
260.00
|
-
|
-
|
-
|
|
22/03/2023
|
1
|
1
|
1.31
|
1
|
1
|
1.31
|
|
23/03/2023
|
2
|
201
|
261.30
|
1
|
1
|
1.36
|
|
24/03/2023
|
1
|
1
|
1.34
|
2
|
201
|
271.35
|
|
27/03/2023
|
2
|
200
|
260.00
|
-
|
-
|
-
|
|
28/03/2023
|
1
|
1
|
1.35
|
1
|
1
|
1.35
|
|
29/03/2023
|
2
|
201
|
261.30
|
2
|
101
|
136.35
|
|
30/03/2023
|
1
|
1
|
1.30
|
1
|
1
|
1.30
|
|
31/03/2023
|
1
|
1
|
1.31
|
1
|
1
|
1.31
|
|
03/04/2023
|
1
|
200
|
250.00
|
-
|
-
|
-
|
|
DATE
|
BUY SIDE
|
SELL SIDE
|
|
Number of executions
|
Number of shares
|
Traded volume in EUR
|
Number of executions
|
Number of shares
|
Traded volume in EUR
|
|
05/04/2023
|
1
|
1
|
1.24
|
1
|
1
|
1.24
|
|
06/04/2023
|
-
|
-
|
-
|
2
|
400
|
532.00
|
|
11/04/2023
|
1
|
200
|
260.00
|
-
|
-
|
-
|
|
13/04/2023
|
2
|
201
|
251.25
|
2
|
200
|
260.00
|
|
14/04/2023
|
5
|
1 500
|
1 815.00
|
1
|
1
|
1.30
|
|
17/04/2023
|
2
|
200
|
234.00
|
1
|
200
|
250.00
|
|
18/04/2023
|
1
|
200
|
250.00
|
-
|
-
|
-
|
|
20/04/2023
|
1
|
1
|
1.25
|
1
|
1
|
1.25
|
|
21/04/2023
|
1
|
1
|
1.20
|
-
|
-
|
-
|
|
24/04/2023
|
2
|
200
|
242.00
|
-
|
-
|
-
|
|
25/04/2023
|
-
|
-
|
-
|
1
|
200
|
250.00
|
|
04/05/2023
|
2
|
65
|
81.25
|
-
|
-
|
-
|
|
05/05/2023
|
1
|
135
|
168.75
|
-
|
-
|
-
|
|
09/05/2023
|
1
|
1
|
1.29
|
3
|
401
|
517.29
|
|
10/05/2023
|
1
|
199
|
256.71
|
-
|
-
|
-
|
|
11/05/2023
|
4
|
400
|
516.00
|
2
|
1 200
|
1 668.00
|
|
12/05/2023
|
4
|
800
|
1 104.00
|
2
|
517
|
739.31
|
|
15/05/2023
|
5
|
200
|
280.00
|
-
|
-
|
-
|
|
16/05/2023
|
4
|
600
|
816.00
|
-
|
-
|
-
|
|
17/05/2023
|
1
|
9
|
11.97
|
-
|
-
|
-
|
|
18/05/2023
|
4
|
601
|
793.32
|
1
|
1
|
1.34
|
|
19/05/2023
|
5
|
600
|
804.00
|
-
|
-
|
-
|
|
22/05/2023
|
4
|
800
|
1 032.00
|
1
|
1
|
1.35
|
|
23/05/2023
|
1
|
1
|
1.35
|
2
|
50
|
67.50
|
|
25/05/2023
|
1
|
43
|
54.18
|
-
|
-
|
-
|
|
26/05/2023
|
1
|
1
|
1.30
|
1
|
1
|
1.30
|
|
29/05/2023
|
2
|
11
|
13.86
|
1
|
1
|
1.30
|
|
30/05/2023
|
1
|
1
|
1.30
|
1
|
1
|
1.30
|
|
31/05/2023
|
3
|
348
|
445.44
|
1
|
1
|
1.34
|
|
01/06/2023
|
3
|
201
|
261.30
|
1
|
1
|
1.30
|
|
DATE
|
BUY SIDE
|
SELL SIDE
|
|
Number of executions
|
Number of shares
|
Traded volume in EUR
|
Number of executions
|
Number of shares
|
Traded volume in EUR
|
|
02/06/2023
|
1
|
1
|
1.30
|
1
|
1
|
1.30
|
|
05/06/2023
|
3
|
200
|
260.00
|
-
|
-
|
-
|
|
08/06/2023
|
1
|
200
|
260.00
|
-
|
-
|
-
|
|
09/06/2023
|
1
|
1
|
1.30
|
1
|
1
|
1.30
|
|
12/06/2023
|
2
|
100
|
128.00
|
-
|
-
|
-
|
|
13/06/2023
|
1
|
100
|
126.00
|
-
|
-
|
-
|
|
15/06/2023
|
1
|
1
|
1.29
|
1
|
1
|
1.29
|
|
19/06/2023
|
1
|
1
|
1.29
|
1
|
1
|
1.29
|
|
20/06/2023
|
4
|
326
|
407.50
|
1
|
1
|
1.27
|
|
21/06/2023
|
2
|
76
|
94.24
|
1
|
1
|
1.25
|
|
22/06/2023
|
1
|
1
|
1.25
|
1
|
1
|
1.25
|
|
23/06/2023
|
2
|
31
|
37.82
|
1
|
1
|
1.24
|
|
26/06/2023
|
1
|
170
|
207.40
|
2
|
200
|
250.00
|
|
27/06/2023
|
1
|
1
|
1.24
|
4
|
54
|
67.50
|
|
28/06/2023
|
4
|
400
|
484.00
|
1
|
1
|
1.25
|
|
30/06/2023
|
2
|
400
|
472.00
|
-
|
-
|
-
|
|
TOTAL
|
245
|
35 717
|
50 544.84
|
129
|
21 629
|
32 173.80
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
About Affluent Medical
Affluent Medical is a French MedTech company, founded by Truffle Capital, with the ambition to become a global leader in the treatment of structural heart diseases, which are the world's leading cause of mortality, and urinary incontinence which currently affects one in four adults.
Affluent Medical develops next-generation, mini-invasive, innovative, adjustable, and biomimetic implants to restore critical physiological functions. The product candidates developed by the Company are currently in preclinical and clinical studies.
Subject to raising the necessary funds to finance its strategy and to positive results from ongoing clinical studies, the Company's ambition is to progressively commercialize its products starting in 2025.
For more information: www.affluentmedical.com
Contacts:
|
AFFLUENT MEDICAL
Sébastien LADET
Chief Executive Officer
[email protected]
|
ACTIFIN, financial communications/financial press relations
Ghislaine GASPARETTO/ Jennifer JULLIA
+33 (0)6 21 10 49 24/ +33 (0)1 56 88 11 19
[email protected]/ jjullia@actifin.fr
|
|
PRIMATICE, public relations France
Thomas ROBOREL de CLIMENS
+33 (0)6 78 12 97 95
[email protected]
|
MC Services AG
Caroline BERGMANN / Kirsten RÜHL
+49 (0)211 529252 20 / +49 (0)211 529252 16
[email protected]
|
